V-ATPase subunit interactions: the long road to therapeutic targeting

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry
• Drug Discovery

Background:

• Vacuolar ATPases (V-ATPases) are ubiquitous proton pumps essential for cellular processes in eukaryotes and prokaryotes.
• These molecular motors play critical roles in development, tissue function, and pH homeostasis.
• Dysfunctional V-ATPases are linked to various diseases, including bone pathologies, renal tubular acidosis, and cancer metastasis.

Purpose of the Study:

• To review the historical contributions to understanding V-ATPase structure and function.
• To present ongoing efforts in translating basic V-ATPase research into drug discovery tools.
• To focus on developing therapeutic strategies for bone-loss pathologies like osteoporosis.

Main Methods:

• Review of established V-ATPase research and the authors' contributions.
• Development of a drug screening strategy targeting V-ATPase function.
• Focus on specific V-ATPase subunit interactions, particularly a3-B2 subunit interactions.

Main Results:

• Demonstrated the critical role of V-ATPases in fundamental cellular functions and disease pathogenesis.
• Established proof-of-concept for a novel drug screening strategy.
• Identified targeting a3-B2 subunit interactions as a potential therapeutic approach for bone-loss disorders.

Conclusions:

• V-ATPases are crucial targets for therapeutic intervention due to their involvement in vital processes and diseases.
• The presented drug screening strategy offers a promising avenue for developing treatments for bone-loss pathologies.
• Further research into V-ATPase cell and molecular biology is essential for advancing drug discovery.